Official name: | Arab Republic of Egypt |
---|---|
WRLFMD code: | EGY |
FMD first recorded: | |
FMD eradicated: | |
Subsequent outbreaks: | |
Serotypes (last rpt): | |
Current status: | Endemic |
Useful websites: |
FMDV Serotype | Years (not comprehensive) |
---|---|
Untyped | 2008, 2009, 2011-2015, 2017, 2018 |
O | 1951, 1958, 1961-1962, 1964-1977, 1978-1982, 1987, 1989-1994, 1997, 2000, 2006-2009, 2011-2017, 2021, 2022 |
A | 1952 (or 1953?), 1956, 1958, 1972, 2006, 2009-2013, 2015-2018, 2020-2022 |
C | - |
Asia 1 | - |
SAT 1 | - |
SAT 2 | 1950, 2012, 2014-2018 |
SAT 3 | - |
Notes | - |
WRLFMD batch no. | Date Received | Virus samples | Type | Topotype | Lineage | Sublineage | WRLFMD Reports |
---|---|---|---|---|---|---|---|
WRLFMD/2006/00007 | 19/02/2006 | EGY/1/2006 | A | AFRICA | G-VII | KEN-05 | Detection Genotyping(A) Vaccine(A) Vaccine(A,sup1) Vaccine(A,sup2) Vaccine(A,sup3) |
EGY/2/2006 | A | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2006/00008 | 01/03/2006 | EGY/3/2006 | A | AFRICA | G-VII | KEN-05 | Detection |
EGY/4/2006 | A | AFRICA | G-VII | KEN-05 | |||
EGY/5/2006 | A | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2007/00010 | 27/04/2007 | EGY/8/2006 | O | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Genotyping(A) Vaccine(A) |
EGY/6/2006 | A | AFRICA | G-VII | KEN-05 | |||
EGY/7/2006 | A | AFRICA | G-VII | KEN-05 | |||
EGY/9/2006 | A | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2007/00144 | 12/10/2007 | EGY/25/2007 | O (GD) | ME-SA | PanAsia-2 | - | Detection Genotyping(O) |
EGY/26/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/27/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/28/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/29/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/30/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/31/2007 | O (GD) | ME-SA | PanAsia-2 | - | |||
EGY/1/2007 | NVD | ||||||
EGY/2/2007 | NVD | ||||||
EGY/3/2007 | NVD | ||||||
EGY/4/2007 | NVD | ||||||
EGY/5/2007 | NVD | ||||||
EGY/6/2007 | NVD | ||||||
EGY/7/2007 | NVD | ||||||
EGY/8/2007 | NVD | ||||||
EGY/9/2007 | NVD | ||||||
EGY/10/2007 | NVD | ||||||
EGY/11/2007 | NVD | ||||||
EGY/12/2007 | NVD | ||||||
EGY/13/2007 | NVD | ||||||
EGY/14/2007 | NVD | ||||||
EGY/15/2007 | NVD | ||||||
EGY/16/2007 | NVD | ||||||
EGY/17/2007 | NVD | ||||||
EGY/18/2007 | NVD | ||||||
EGY/19/2007 | NVD | ||||||
EGY/20/2007 | NVD | ||||||
EGY/21/2007 | NVD | ||||||
EGY/22/2007 | NVD | ||||||
EGY/23/2007 | NVD | ||||||
EGY/24/2007 | NVD | ||||||
EGY/32/2007 | NVD | ||||||
EGY/33/2007 | NVD | ||||||
EGY/34/2007 | NVD | ||||||
EGY/35/2007 | NVD | ||||||
EGY/36/2007 | NVD | ||||||
EGY/37/2007 | NVD | | |||||
WRLFMD/2009/00012 | 19/03/2009 | EGY/10/2006 | O | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Genotyping(A) Vaccine(O) Vaccine(A) |
EGY/11/2006 | O | ME-SA | Sharqia-72 | - | |||
EGY/1/2008 | O | ME-SA | Sharqia-72 | - | |||
EGY/3/2008 | O | ME-SA | Sharqia-72 | - | |||
EGY/4/2008 | O | ME-SA | Sharqia-72 | - | |||
EGY/5/2008 | O | ME-SA | Sharqia-72 | - | |||
EGY/7/2008 | O | ME-SA | Sharqia-72 | - | |||
EGY/1/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/6/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/8/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/3/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/4/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/7/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/9/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/12/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/13/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/14/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/15/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/16/2009 | A | AFRICA | G-VII | KEN-05 | |||
EGY/8/2009 | A & O | nd | - | - | |||
EGY/10/2009 | A & O | nd | - | - | |||
EGY/2/2008 | FMDV‑GD | nd | - | - | |||
EGY/6/2008 | FMDV‑GD | nd | - | - | |||
EGY/5/2009 | FMDV‑GD | nd | - | - | |||
EGY/2/2009 | NVD | ||||||
EGY/11/2009 | NVD | ||||||
WRLFMD/2009/00028 | 28/05/2009 | EGY/17/2009 | O | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Vaccine(O) |
EGY/18/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/19/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/20/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/21/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/22/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/23/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/24/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/25/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/26/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/27/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/28/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/29/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/30/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/31/2009 | O | ME-SA | Sharqia-72 | - | |||
EGY/32/2009 | O | ME-SA | Sharqia-72 | - | |||
WRLFMD/2012/00011 | 12/03/2012 | EGY/6/2011 | O | ME-SA | PanAsia-2 | - | Detection Genotyping(A) Genotyping(SAT2) Vaccine(O) Vaccine(A) Vaccine(SAT2) Vaccine(SAT2, sup) |
EGY/7/2011 | O | ME-SA | PanAsia-2 | - | |||
EGY/10/2011 | O | ME-SA | PanAsia-2 | - | |||
EGY/1/2010 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/2/2010 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/3/2010 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/2/2011 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/5/2011 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/8/2011 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/9/2011 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/1/2012 | A | AFRICA | G-IV | ISM-12 | |||
EGY/2/2012 | SAT 2 | VII | Alx-12 | - | |||
EGY/3/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/4/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/5/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/6/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/9/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/10/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/11/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/13/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/14/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/15/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/1/2011 | FMDV‑GD | nd | - | - | |||
EGY/3/2011 | FMDV‑GD | nd | - | - | |||
EGY/4/2011 | FMDV‑GD | nd | - | - | |||
EGY/7/2012 | FMDV‑GD | nd | - | - | |||
EGY/8/2012 | FMDV‑GD | nd | - | - | |||
EGY/12/2012 | NVD | ||||||
WRLFMD/2012/00032 | 02/10/2012 | EGY/19/2012 | O | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(O,sup) Genotyping(A) Genotyping (SAT2) Vaccine(O) Vaccine(O,sup) Vaccine(A) Vaccine(SAT2) |
EGY/25/2012 | O | EA-3 | unnamed | - | |||
EGY/26/2012 | O | EA-3 | unnamed | - | |||
EGY/27/2012 | O | EA-3 | unnamed | - | |||
EGY/18/2012 | A | AFRICA | G-IV | - | |||
EGY/20/2012 | A | AFRICA | G-IV | - | |||
EGY/30/2012 | A | AFRICA | G-IV | - | |||
EGY/16/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/17/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/21/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/22/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/28/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/29/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/31/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/23/2012 | FMDV‑GD | nd | - | - | |||
EGY/24/2012 | FMDV‑GD | nd | - | - | |||
EGY/35/2012 | FMDV‑GD | nd | - | - | |||
EGY/36/2012 | FMDV‑GD | nd | - | - | |||
EGY/32/2012 | NVD | ||||||
EGY/33/2012 | NVD | ||||||
EGY/34/2012 | NVD | ||||||
WRLFMD/2013/00012 | 29/05/2013 | EGY/3/2013 | A | ASIA | Iran-05 | BAR-08 | Detection Genotyping(A) Vaccine(A) Vaccine(A,sup) |
EGY/5/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/6/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/11/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/12/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/13/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/14/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/15/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/17/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/19/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/37/2012 | FMDV‑GD | nd | - | - | |||
EGY/38/2012 | FMDV‑GD | nd | - | - | |||
EGY/40/2012 | FMDV‑GD | nd | - | - | |||
EGY/1/2013 | FMDV‑GD | nd | - | - | |||
EGY/2/2013 | FMDV‑GD | nd | - | - | |||
EGY/4/2013 | FMDV‑GD | nd | - | - | |||
EGY/7/2013 | FMDV‑GD | nd | - | - | |||
EGY/8/2013 | FMDV‑GD | nd | - | - | |||
EGY/9/2013 | FMDV‑GD | nd | - | - | |||
EGY/39/2012 | NVD | ||||||
EGY/41/2012 | NVD | ||||||
EGY/10/2013 | NVD | ||||||
EGY/16/2013 | NVD | ||||||
EGY/18/2013 | NVD | ||||||
EGY/20/2013 | NVD | ||||||
WRLFMD/2014/00017 | 23/04/2014 | EGY/24/2013 | O | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine(O) Vaccine(A) Vaccine(SAT 2) |
EGY/25/2013 | O | EA-3 | unnamed | - | |||
EGY/28/2013 | O | EA-3 | unnamed | - | |||
EGY/29/2013 | O | EA-3 | unnamed | - | |||
EGY/1/2014 | O | EA-3 | unnamed | - | |||
EGY/3/2014 | O | EA-3 | unnamed | - | |||
EGY/4/2014 | O | EA-3 | unnamed | - | |||
EGY/5/2014 | O | EA-3 | unnamed | - | |||
EGY/6/2014 | O | EA-3 | unnamed | - | |||
EGY/10/2014 | O | EA-3 | unnamed | - | |||
EGY/18/2014 | O | EA-3 | unnamed | - | |||
EGY/21/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/22/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/11/2014 | SAT 2 | VII | Alx-12 | - | |||
EGY/20/2014 | SAT 2 | VII | Alx-12 | - | |||
EGY/22/2014 | SAT 2 | VII | Alx-12 | - | |||
EGY/23/2013 | FMDV‑GD | nd | - | - | |||
EGY/27/2013 | FMDV‑GD | nd | - | - | |||
EGY/7/2014 | FMDV‑GD | nd | - | - | |||
EGY/8/2014 | FMDV‑GD | nd | - | - | |||
EGY/9/2014 | FMDV‑GD | nd | - | - | |||
EGY/12/2014 | FMDV‑GD | nd | - | - | |||
EGY/13/2014 | FMDV‑GD | nd | - | - | |||
EGY/14/2014 | FMDV‑GD | nd | - | - | |||
EGY/15/2014 | FMDV‑GD | nd | - | - | |||
EGY/16/2014 | FMDV‑GD | nd | - | - | |||
EGY/19/2014 | FMDV‑GD | nd | - | - | |||
EGY/21/2014 | FMDV‑GD | nd | - | - | |||
EGY/26/2013 | NVD | ||||||
EGY/2/2014 | NVD | ||||||
EGY/17/2014 | NVD | ||||||
WRLFMD/2014/00037 | 04/11/2014 | EGY/23/2014 | O | EA-3 | unnamed | - | Detection Genotyping(A) Genotyping(SAT 2) Vaccine(O) Vaccine(SAT 2) |
EGY/25/2014 | O | EA-3 | unnamed | - | |||
EGY/26/2014 | O | EA-3 | unnamed | - | |||
EGY/27/2014 | O | EA-3 | unnamed | - | |||
EGY/28/2014 | O | EA-3 | unnamed | - | |||
EGY/29/2014 | O | EA-3 | unnamed | - | |||
EGY/32/2014 | O | EA-3 | unnamed | - | |||
EGY/34/2014 | O | EA-3 | unnamed | - | |||
EGY/36/2014 | O | EA-3 | unnamed | - | |||
EGY/42/2012 | A | AFRICA | G-IV | - | |||
EGY/30/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/31/2013 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/31/2014 | A | ASIA | Iran-05 | BAR-08 | |||
EGY/43/2012 | SAT 2 | VII | Ghb-12 | - | |||
EGY/24/2014 | SAT 2 | VII | Alx-12 | - | |||
EGY/30/2014 | FMDV‑GD | nd | - | - | |||
EGY/33/2014 | FMDV‑GD | nd | - | - | |||
EGY/35/2014 | FMDV‑GD | nd | - | - | |||
EGY/37/2014 | NVD | ||||||
EGY/38/2014 | NVD | ||||||
EGY/39/2014 | NVD | ||||||
EGY/40/2014 | NVD | ||||||
EGY/41/2014 | NVD | ||||||
EGY/42/2014 | NVD | ||||||
EGY/43/2014 | NVD | ||||||
EGY/44/2014 | NVD | ||||||
EGY/45/2014 | NVD | ||||||
EGY/46/2014 | NVD | ||||||
WRLMEG/2015/00010 | 15/07/2015 | RL-440/EGY/2014* | O | EA-3 | unnamed | - | Genotyping(O) Genotyping(A) |
RL-453/EGY/2014* | O | EA-3 | unnamed | - | |||
RL-455/EGY/2014* | O | EA-3 | unnamed | - | |||
RL-902/EGY/2015* | O | EA-3 | unnamed | - | |||
RL-936/EGY/2015* | O | EA-3 | unnamed | - | |||
RL-937/EGY/2015* | O | EA-3 | unnamed | - | |||
RL-939/EGY/2015* | O | EA-3 | unnamed | - | |||
RL-940/EGY/2015* | O | EA-3 | unnamed | - | |||
RL-464/EGY/2014* | A | ASIA | Iran-05 | BAR-08 | |||
RL-932/EGY/2015* | A | ASIA | Iran-05 | BAR-08 | |||
WRLFMD/2016/00017 | 14/06/2016 | EGY/11/2011 | O | ME-SA | Sharqia‑72 | - | Detection Genotyping(O) Vaccine |
EGY/44/2012 | SAT2 | VII | Ghb‑12 | - | |||
EGY/1/2015 | NVD | ||||||
WRLFMD/2016/00024 | 14/06/2016 | EGY/3/2015 | O | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine |
EGY/9/2015 | O | EA-3 | unnamed | - | |||
EGY/10/2015 | O | EA-3 | unnamed | - | |||
EGY/11/2015 | O | EA-3 | unnamed | - | |||
EGY/13/2015 | O | EA-3 | unnamed | - | |||
EGY/14/2015 | O | EA-3 | unnamed | - | |||
EGY/4/2016 | O | EA-3 | unnamed | - | |||
EGY/5/2016 | O | EA-3 | unnamed | - | |||
EGY/7/2016 | O | EA-3 | unnamed | - | |||
EGY/8/2016 | O | EA-3 | unnamed | - | |||
EGY/9/2016 | O | EA-3 | unnamed | - | |||
EGY/10/2016 | O | EA-3 | unnamed | - | |||
EGY/11/2016 | O | EA-3 | unnamed | - | |||
EGY/12/2016 | O | EA-3 | unnamed | - | |||
EGY/14/2016 | O | EA-3 | unnamed | - | |||
EGY/16/2016 | O | EA-3 | unnamed | - | |||
EGY/17/2016 | O | EA-3 | unnamed | - | |||
EGY/18/2016 | O | EA-3 | unnamed | - | |||
EGY/8/2015 | A | AFRICA | G-IV | - | |||
EGY/3/2016 | A | AFRICA | G-IV | - | |||
EGY/5/2015 | SAT 2 | VII | Alx-12 | - | |||
EGY/2/2015 | FMDV‑GD | nd | - | - | |||
EGY/4/2015 | NVD | ||||||
EGY/6/2015 | NVD | ||||||
EGY/7/2015 | NVD | ||||||
EGY/12/2015 | NVD | ||||||
EGY/15/2015 | NVD | ||||||
EGY/1/2016 | NVD | ||||||
EGY/2/2016 | NVD | ||||||
EGY/6/2016 | NVD | ||||||
EGY/13/2016 | NVD | ||||||
EGY/15/2016 | NVD | ||||||
WRLFMD/2017/00014 | 05/07/2017 | EGY/4/2017 | O | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Vaccine |
EGY/6/2017 | O | EA-3 | unnamed | - | |||
EGY/7/2017 | O | EA-3 | unnamed | - | |||
EGY/8/2017 | O | EA-3 | unnamed | - | |||
EGY/9/2017 | O | EA-3 | unnamed | - | |||
EGY/10/2017 | O | EA-3 | unnamed | - | |||
EGY/11/2017 | O | EA-3 | unnamed | - | |||
EGY/13/2017 | O | EA-3 | unnamed | - | |||
EGY/16/2017 | O | EA-3 | unnamed | - | |||
EGY/17/2017 | O | EA-3 | unnamed | - | |||
EGY/19/2017 | O | EA-3 | unnamed | - | |||
EGY/21/2017 | O | EA-3 | unnamed | - | |||
EGY/22/2017 | O | EA-3 | unnamed | - | |||
EGY/25/2017 | O | EA-3 | unnamed | - | |||
EGY/26/2017 | O | EA-3 | unnamed | - | |||
EGY/27/2017 | O | EA-3 | unnamed | - | |||
EGY/28/2017 | O | EA-3 | unnamed | - | |||
EGY/30/2017 | O | EA-3 | unnamed | - | |||
EGY/31/2017 | O | EA-3 | unnamed | - | |||
EGY/32/2017 | O | EA-3 | unnamed | - | |||
EGY/33/2017 | O | EA-3 | unnamed | - | |||
EGY/19/2016 | A | AFRICA | G-IV | - | |||
EGY/1/2017 | FMDV‑GD | nd | - | - | |||
EGY/2/2017 | FMDV‑GD | nd | - | - | |||
EGY/5/2017 | FMDV‑GD | nd | - | - | |||
EGY/12/2017 | FMDV‑GD | nd | - | - | |||
EGY/14/2017 | FMDV‑GD | nd | - | - | |||
EGY/15/2017 | FMDV‑GD | nd | - | - | |||
EGY/20/2017 | FMDV‑GD | nd | - | - | |||
EGY/23/2017 | FMDV‑GD | nd | - | - | |||
EGY/24/2017 | FMDV‑GD | nd | - | - | |||
EGY/29/2017 | FMDV‑GD | nd | - | - | |||
EGY/20/2016 | NVD | ||||||
EGY/3/2017 | NVD | ||||||
EGY/18/2017 | NVD | ||||||
WRLMEG/2018/00004 | 16/01/2018 | Ismailia 12/Egy/2016* | O | EA-3 | - | - | Genotyping(O) Genotyping(A) Genotyping(SAT 2) |
Ismailia 13/Egy/2016* | O | EA-3 | - | - | |||
Alexandria 1/Egy/2016* | O | EA-3 | - | - | |||
Alexandria 1/Egy/2017* | O | EA-3 | - | - | |||
Giza 1/Egy/2017* | O | EA-3 | - | - | |||
Cairo 1/Egy/2017* | O | EA-3 | - | - | |||
Sharkia 1/Egy/2017* | O | EA-3 | - | - | |||
Gharbia 1/Egy/2017* | O | EA-3 | - | - | |||
Behira 1/Egy/2017* | O | EA-3 | - | - | |||
Behira 2/Egy/2017* | O | EA-3 | - | - | |||
Fayoum 1/Egy/2017* | O | EA-3 | - | - | |||
Fayoum 2/Egy/2017* | O | EA-3 | - | - | |||
Fayoum 3/Egy/2017* | O | EA-3 | - | - | |||
Fayoum 4/Egy/2017* | O | EA-3 | - | - | |||
Fayoum 5/Egy/2017* | O | EA-3 | - | - | |||
Beni-suef 1/Egy/2017* | A | AFRICA | G-IV | - | |||
Daqahlia 1/Egy/2017* | SAT 2 | VII | Alx-12 | - | |||
Daqahlia 2/Egy/2017* | SAT 2 | VII | Alx-12 | - | |||
Fayoum 1/Egy/2017* | SAT 2 | VII | Alx-12 | - | |||
WRLFMD/2019/00005 | 16/01/2019 | EGY/34/2017 | O | EA‑3 | - | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT2) Vaccine Vaccine(sup) |
EGY/2/2018 | A | AFRICA | G‑IV | - | |||
EGY/1/2018 | SAT 2 | VII | Ghb‑12 | - | |||
EGY/7/2018 | SAT 2 | VII | Lib‑12 | - | |||
EGY/19/2018 | SAT 2 | VII | Lib‑12 | - | |||
EGY/21/2018 | SAT 2 | VII | Lib‑12 | - | |||
EGY/31/2018 | SAT 2 | VII | Lib‑12 | - | |||
EGY/34/2018 | SAT 2 | VII | Lib‑12 | - | |||
EGY/3/2018 | FMDV‑GD | nd | - | - | |||
EGY/5/2018 | FMDV‑GD | nd | - | - | |||
EGY/9/2018 | FMDV‑GD | nd | - | - | |||
EGY/10/2018 | FMDV‑GD | nd | - | - | |||
EGY/11/2018 | FMDV‑GD | nd | - | - | |||
EGY/12/2018 | FMDV‑GD | nd | - | - | |||
EGY/16/2018 | FMDV‑GD | nd | - | - | |||
EGY/17/2018 | FMDV‑GD | nd | - | - | |||
EGY/18/2018 | FMDV‑GD | nd | - | - | |||
EGY/20/2018 | FMDV‑GD | nd | - | - | |||
EGY/25/2018 | FMDV‑GD | nd | - | - | |||
EGY/26/2018 | FMDV‑GD | nd | - | - | |||
EGY/27/2018 | FMDV‑GD | nd | - | - | |||
EGY/28/2018 | FMDV‑GD | nd | - | - | |||
EGY/29/2018 | FMDV‑GD | nd | - | - | |||
EGY/30/2018 | FMDV‑GD | nd | - | - | |||
EGY/32/2018 | FMDV‑GD | nd | - | - | |||
EGY/33/2018 | FMDV‑GD | nd | - | - | |||
EGY/35/2018 | FMDV‑GD | nd | - | - | |||
EGY/4/2018 | NVD | ||||||
EGY/6/2018 | NVD | ||||||
EGY/8/2018 | NVD | ||||||
EGY/13/2018 | NVD | ||||||
EGY/14/2018 | NVD | ||||||
EGY/15/2018 | NVD | ||||||
EGY/22/2018 | NVD | ||||||
EGY/23/2018 | NVD | ||||||
EGY/24/2018 | NVD | | | ||||
WRLMEG/2020/00004 | 28/01/2020 | EGY/Sharqia1/2018* | SAT 2 | VII | Lib-12 | - | Genotyping(SAT2) |
EGY/Sharqia2/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Sharqia3/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Sharqia4/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Ismailia1/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Ismailia2/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Ismailia3/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Ismailia4/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Alexandria1/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Alexandria2/2018* | SAT 2 | VII | Lib-12 | - | |||
EGY/Alexandria3/2018* | SAT 2 | VII | Lib-12 | - | |||
WRLMEG/2022/00019 | 25/06/2022 | Egy/Sharquia1/22 * | O | EURO-SA | - | - | Genotyping(O) |
WRLFMD/2022/000090 | 08/12/2022 | EGY 8/2021 | O | EA-3 | - | - | Detection Genotyping(O) Genotyping(A) Vaccine |
EGY 9/2021 | O | EA-3 | - | - | |||
EGY 10/2021 | O | EA-3 | - | - | |||
EGY 2/2020 | A | Africa | G-IV | - | |||
EGY 9/2020 | A | Africa | G-IV | - | |||
EGY 13/2020 | A | Africa | G-IV | - | |||
EGY 14/2020 | A | Africa | G-IV | - | |||
EGY 17/2020 | A | Africa | G-IV | - | |||
EGY 18/2020 | A | Africa | G-IV | - | |||
EGY 19/2020 | A | Africa | G-IV | - | |||
EGY 20/2020 | A | Africa | G-IV | - | |||
EGY 21/2020 | A | Africa | G-IV | - | |||
EGY 1/2021 | A | Africa | G-IV | - | |||
EGY 5/2021 | A | Africa | G-IV | - | |||
EGY 7/2021 | A | Africa | G-IV | - | |||
EGY 1/2022 | A | Africa | G-IV | - | |||
EGY 7/2020 | A† | Africa | G-IV | - | |||
EGY 2/2022 | A† | EURO-SA | - | - | |||
EGY 1/2020 | NVD | ||||||
EGY 3/2020 | NVD | ||||||
EGY 4/2020 | NVD | ||||||
EGY 5/2020 | NVD | ||||||
EGY 6/2020 | NVD | ||||||
EGY 8/2020 | NVD | ||||||
EGY 10/2020 | NVD | ||||||
EGY 11/2020 | NVD | ||||||
EGY 12/2020 | NVD | ||||||
EGY 15/2020 | NVD | ||||||
EGY 16/2020 | NVD | ||||||
EGY 2/2021 | NVD | ||||||
EGY 3/2021 | NVD | ||||||
EGY 4/2021 | NVD | ||||||
EGY 6/2021 | NVD | ||||||
EGY 3/2022 | NVD |
Notes:
nd, not done
*, Not a WRLFMD reference number (only VP1 sequence received)
†, originally reported as FMDV‑GD.